Literature DB >> 15738346

PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites.

Gitte Andersen1, Lise Wegner, Dorit Packert Jensen, Charlotte Glümer, Lise Tarnow, Thomas Drivsholm, Pernille Poulsen, Sara Kristine Hansen, Eva-Maria Damsgaard Nielsen, Jakob Ek, Peter Mouritzen, Allan Vaag, Hans-Henrik Parving, Knut Borch-Johnsen, Torben Jørgensen, Torben Hansen, Oluf Pedersen.   

Abstract

PGC-1alpha is a coactivator of numerous transcription factors and is expressed in tissues with high energy demands and abundant in mitochondria. It is induced in the myocardium on fasting and physical exercise, and cardiac-specific overexpression stimulates mitochondrial biogenesis in mice. The common Gly482Ser polymorphism of PGC-1alpha has previously shown association with arterial hypertension among Austrian men. Thus, we aimed at investigating this relationship in the Danish white population. The Gly482Ser polymorphism was genotyped in a total of 2562 Danish white subjects using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and a GenoView locked nucleic acid assay (LNA), and the relationships of this variant with blood pressure levels and arterial hypertension were analyzed. Furthermore, we performed a combined analysis of the data from the present study in combination with previously published results. The Ser/Ser genotype was significantly associated with a reduced risk of hypertension and with lower systolic, diastolic, and mean arterial blood pressure levels, predominantly among women. Finally, in a combined analysis using data obtained in both sexes, the Ser/Ser genotype group had an estimated odds ratio of 0.70 (95% confidence interval, 0.56 to 0.86) for hypertension compared with Gly/X carriers (P=0.001). In conclusion, the Ser allele of PGC-1alpha Gly482Ser confers a significantly reduced risk of hypertension in whites. Further studies are needed to elucidate the differential role of this polymorphism in men and women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15738346     DOI: 10.1161/01.HYP.0000158946.53289.24

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets.

Authors:  David M Lonard; Bert W O'Malley
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

Review 2.  PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes.

Authors:  S Soyal; F Krempler; H Oberkofler; W Patsch
Journal:  Diabetologia       Date:  2006-05-17       Impact factor: 10.122

Review 3.  Hereditary determinants of human hypertension: strategies in the setting of genetic complexity.

Authors:  Pei-an Betty Shih; Daniel T O'Connor
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

Review 4.  Minireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?

Authors:  David M Lonard; Rakesh Kumar; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2009-10-21

5.  Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.

Authors:  A Rojek; M Cielecka-Prynda; M Przewlocka-Kosmala; L Laczmanski; A Mysiak; W Kosmala
Journal:  J Hum Hypertens       Date:  2014-04-10       Impact factor: 3.012

Review 6.  Role of Mitochondrial Dysfunction in Hypertension and Obesity.

Authors:  Vicente Lahera; Natalia de Las Heras; Antonio López-Farré; Walter Manucha; León Ferder
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

7.  Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.

Authors:  Tessa Schillemans; Vinicius Tragante; Buamina Maitusong; Bruna Gigante; Sharon Cresci; Federica Laguzzi; Max Vikström; Mark Richards; Anna Pilbrow; Vicky Cameron; Luisa Foco; Robert N Doughty; Pekka Kuukasjärvi; Hooman Allayee; Jaana A Hartiala; W H Wilson Tang; Leo-Pekka Lyytikäinen; Kjell Nikus; Jari O Laurikka; Sundararajan Srinivasan; Ify R Mordi; Stella Trompet; Adriaan Kraaijeveld; Jessica van Setten; Crystel M Gijsberts; Anke H Maitland-van der Zee; Christoph H Saely; Yan Gong; Julie A Johnson; Rhonda M Cooper-DeHoff; Carl J Pepine; Gavino Casu; Andreas Leiherer; Heinz Drexel; Benjamin D Horne; Sander W van der Laan; Nicola Marziliano; Stanley L Hazen; Juha Sinisalo; Mika Kähönen; Terho Lehtimäki; Chim C Lang; Ralph Burkhardt; Markus Scholz; J Wouter Jukema; Niclas Eriksson; Axel Åkerblom; Stefan James; Claes Held; Emil Hagström; John A Spertus; Ale Algra; Ulf de Faire; Agneta Åkesson; Folkert W Asselbergs; Riyaz S Patel; Karin Leander
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

8.  Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.

Authors:  Joanne Clark; Sonika Reddy; Kangni Zheng; Rebecca A Betensky; David K Simon
Journal:  BMC Med Genet       Date:  2011-05-19       Impact factor: 2.103

9.  The impact of severity of hypertension on association of PGC-1alpha gene with blood pressure and risk of hypertension.

Authors:  Gaoqiang Xie; Dongshuang Guo; Ying Li; Shengying Liang; Yangfeng Wu
Journal:  BMC Cardiovasc Disord       Date:  2007-10-31       Impact factor: 2.298

10.  The PPARGC1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men.

Authors:  Erik Ingelsson; Louise Bennet; Martin Ridderstråle; Marianne Söderström; Lennart Råstam; Ulf Lindblad
Journal:  BMC Cardiovasc Disord       Date:  2008-12-11       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.